Promising new combo aims to control multiple myeloma without transplant
NCT ID NCT05623020
First seen Jun 27, 2026 · Last updated Aug 25, 2026 · Updated 4 times
Summary
This study tests whether a new drug combination (elranatamab, daratumumab, and lenalidomide) works better than a standard combination for people newly diagnosed with multiple myeloma who are not eligible for a stem cell transplant. The trial involves about 1,116 participants and will measure how long the cancer stays under control and whether it can be reduced to undetectable levels. The goal is to improve disease control, not to cure the disease, as ongoing treatment is expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 1,116 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2022
- Expected to finish
-
Oct 2033
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of multiple myeloma (MM) as defined by IMWG criteria (Rajkumar et al., 2014) * Measurable disease based on IMWG criteria as defined by at least 1 of the following: * Serum M-protein ≥0.5 g/dL (Part 1) and ≥1 g/dL (Part 2); * Urinary M-protein excretion ≥200 mg/24 hours; * Involved FLC ≥10 mg/dL (≥100 mg/L) AND abnormal serum immunoglobulin kappa to lambda FLC ratio (\<0.26 or \>1.65). * Part 1: Participants with relapsed/refractory multiple myeloma (RRMM) who have received 1-2 prior lines of therapy including at least one immunomodulatory drug and one proteasome inhibitor: or participants with newly-diagnosed multiple myeloma (NDMM) that are transplant-ineligible as defined by age ≥65 years or transplant-ineligible as defined by age \<65 years with comorbidities impacting the possibility of transplant. * Part 2: participants with newly-diagnosed multiple myeloma that are transplant-ineligible defined as: * Participants not considered candidates for high-dose chemotherapy and ASCT due to age or * Participants with important comorbidities likely to have a negative impact on tolerability of high dose chemotherapy and ASCT. * ECOG performance status ≤2. * Not pregnant and willing to use contraception * For participants with RRMM: Resolved acute effects of any prior therapy to baseline severity or CTCAE Grade ≤1. Exclusion Criteria: * Smoldering Multiple Myeloma. * Monoclonal gammopathy of undetermined significance. * Waldenströms Macroglobulinemia * Plasma cell leukemia. * Active, uncontrolled bacterial, fungal, or viral infection, including (but not limited to) COVID-19/SARS-CoV-2, HBV, HCV, and known HIV or AIDS-related illness. * Any other active malignancy within 3 years prior to enrollment, except for adequately treated basal cell or squamous cell skin cancer, carcinoma in situ, or Stage 0/1 with minimal risk of recurrence per investigator. * For participants with RRMM: Previous treatment with a BCMA-directed therapy or anti-CD38-directed therapy within 6 months preceding the first dose of study intervention in this study. Stem cell transplant ≤3 months prior to first dose of study intervention or active GVHD. * For participants with NDMM: Previous systemic treatment for MM except for a short course of corticosteroids (ie, total of 160 mg dexamethasone or equivalent before the first dose of study intervention). A cumulative dose of systemic corticosteroids equivalent to ≥20 mg of dexamethasone during screening. * Live attenuated vaccine administered within 4 weeks of the first dose of study intervention. * Administration of investigational product (eg, drug or vaccine) concurrent with study intervention or within 30 days (or as determined by the local requirement) preceding the first dose of study intervention used in this study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple myeloma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
136 sites in 24 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
"Theagenio" Cancer Hospital of Thessaloniki
RECRUITINGThessaloniki, Kentrikí Makedonía, 540 07, Greece
-
A.O.U. Policlinico Paolo Giaccone
RECRUITINGPalermo, Sicily, 90127, Italy
-
AOU Policlinico Umberto I
RECRUITINGRoma, 00161, Italy
-
ASL PESCARA-Presidio Ospedaliero Pescara
RECRUITINGPescara, 65124, Italy
-
AUSL di Piacenza
RECRUITINGPiacenza, Emilia-Romagna, 29121, Italy
-
AZ Delta vzw
RECRUITINGRoeselare, West-vlaanderen, 8800, Belgium
-
AZ Sint-Jan Brugge-Oostende AV
NOT_YET_RECRUITINGBruges, West-vlaanderen, 8000, Belgium
-
Albert Schweitzer Ziekenhuis, locatie Dordwijk
RECRUITINGDordrecht, South Holland, 3318 AT, Netherlands
-
Alexandra General Hospital of Athens
RECRUITINGAthens, Attikí, 115 28, Greece
-
Asklepiosklinik Altona
NOT_YET_RECRUITINGHamburg, 22763, Germany
-
Auckland City Hospital
RECRUITINGGrafton, Auckland, 1023, New Zealand
-
Auxilio Mutuo Cancer Center
RECRUITINGSan Juan, 00917, Puerto Rico
-
Azienda Ospedaliero Universitaria Pisana
RECRUITINGPisa, Tuscany, 56126, Italy
-
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
RECRUITINGTurin, Piedmont, 10126, Italy
-
Azienda Sanitaria Locale di Pescara
RECRUITINGPescara, 65124, Italy
-
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII
RECRUITINGBergamo, 24127, Italy
-
CHUS - Hospital Clinico Universitario
RECRUITINGSantiago de Compostela, A Coruña [LA Coruña], 15706, Spain
-
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
RECRUITINGNantes, 44093 Cedex 1, France
-
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet
RECRUITINGNice, Alpes-maritimes, 06200, France
-
Centre Hospitalier Universitaire de Poitiers
RECRUITINGPoitiers, Vienne, 86021, France
-
Chang Gung Medical Foundation-Linkou Branch
RECRUITINGTaoyuan, 333, Taiwan
-
China Medical University Hospital
RECRUITINGTaichung, 404332, Taiwan
-
Chonnam National University Hwasun Hospital
RECRUITINGHwasun-gun, Jeonranamdo, 58128, South Korea
-
Churchill Hospital
RECRUITINGOxford, Oxfordshire, OX3 7LE, United Kingdom
-
Clinica Universidad de Navarra
RECRUITINGMadrid, Madrid, Comunidad de, 28027, Spain
-
Clinica Universidad de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
-
Clinique Saint Pierre
RECRUITINGOttignies, Brabant Wallon, 1340, Belgium
-
Cro-Irccs
RECRUITINGAviano, Friuli Venezia Giulia, 33081, Italy
-
Cross Cancer Institute
NOT_YET_RECRUITINGEdmonton, Alberta, T6G 1Z2, Canada
-
Dr. Everett Chalmers Regional Hospital
NOT_YET_RECRUITINGFredericton, New Brunswick, E3B 5N5, Canada
-
Epworth Freemasons
RECRUITINGMelbourne, Victoria, 3002, Australia
-
Epworth Healthcare
RECRUITINGRichmond, Victoria, 3121, Australia
-
Evangelismos General Hospital of Athens
RECRUITINGAthens, Attikí, 106 76, Greece
-
Evangelismos General Hospital of Athens
RECRUITINGAthens, 10676, Greece
-
Ewha Womans University Seoul Hospital
RECRUITINGSeoul, Seoul-teukbyeolsi [seoul], 07804, South Korea
-
Fakultni nemocnice Olomouc
RECRUITINGOlomouc, 779 00, Czechia
-
Fakultní nemocnice Brno Bohunice
RECRUITINGBrno, Brno-město, 625 00, Czechia
-
Fondazione IRCCS San Gerardo dei Tintori
RECRUITINGMonza, Lombardy, 20900, Italy
-
Fujian Medical University Union Hospital
RECRUITINGFuzhou, Fujian, 350001, China
-
Grand Hôpital de Charleroi
RECRUITINGGilly, Hainaut, 6060, Belgium
-
Gunma University Hospital
RECRUITINGMaebashi, Gunma, 371-8511, Japan
-
H.R.U Málaga - Hospital General
RECRUITINGMálaga, 29010, Spain
-
Hadassah Medical Center
RECRUITINGJerusalem, Jerusalem, 9112001, Israel
-
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus)
RECRUITINGHelsinki, 00029, Finland
-
Hospital Clínic de Barcelona
RECRUITINGBarcelona, Catalunya [cataluña], 08036, Spain
-
Hospital La Princesa
RECRUITINGMadrid, 28006, Spain
-
Hospital San Pedro de Alcántara
RECRUITINGCáceres, 10003, Spain
-
Hospital Universitari Mutua Terrassa
RECRUITINGTerrassa, Barcelona [barcelona], 08221, Spain
-
Hospital Universitari i Politecnic La Fe
RECRUITINGValencia, 46026, Spain
-
Hospital Universitario Doctor Peset
RECRUITINGValencia, València, 46017, Spain
-
Hospital Universitario Fundación Jiménez Díaz
RECRUITINGMadrid, 28040, Spain
-
Hospital Universitario Marqués de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
-
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP)
RECRUITINGRibeirão Preto, São Paulo, 14051-140, Brazil
-
Hôpital Saint Antoine
RECRUITINGParis, 75012, France
-
IRCCS Casa Sollievo della Sofferenza
RECRUITINGSan Giovanni Rotondo, FG, 71013, Italy
-
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori- IRST S.r.l
RECRUITINGMeldola (Fc), Emilia-Romagna, 47014, Italy
-
Inselspital Bern
NOT_YET_RECRUITINGBern, Canton of Bern, 3010, Switzerland
-
Institut Català d'Oncologia (ICO) - Badalona
RECRUITINGBadalona, Barcelona [barcelona], 08916, Spain
-
Institut Català d'Oncologia (ICO) - Girona
RECRUITINGGirona, Girona [gerona], 17007, Spain
-
Institut Català d'Oncologia - L'Hospitalet
RECRUITINGL'Hospitalet Del Llobregat, Barcelona [barcelona], 08908, Spain
-
Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE
RECRUITINGToulouse, Haute-garonne, 31100, France
-
Institute of hematology&blood disease hospital
RECRUITINGTianjin, Tianjin Municipality, 300020, China
-
Istituto Europeo di Oncologia IRCCS
RECRUITINGMilan, 20141, Italy
-
Iwate Medical University Hospital
RECRUITINGYahaba-cho, Iwate, 028-3695, Japan
-
Japanese Red Cross Medical Center
RECRUITINGShibuya-ku, Tokyo, 150-8935, Japan
-
Jupiter Medical Center/Anderson Family Cancer Institute
RECRUITINGJupiter, Florida, 33458, United States
-
Kantonsspital Winterthur
NOT_YET_RECRUITINGWinterthur, 8401, Switzerland
-
Klinikum Chemnitz
RECRUITINGChemnitz, 09116, Germany
-
Krankenhaus der Barmherzigen Schwestern Wien
RECRUITINGVienna, State of Vienna, 1060, Austria
-
Kuopion Yliopistollinen Sairaala
RECRUITINGKuopio, Northern Savonia, 70210, Finland
-
Kyushu University Hospital
RECRUITINGFukuoka, 812-8582, Japan
-
Landeskrankenhaus Feldkirch
RECRUITINGRankweil, Vorarlberg, 6830, Austria
-
Leicester Royal Infirmary
RECRUITINGLeicester, England, LE1 5WW, United Kingdom
-
MSK Basking Ridge
RECRUITINGBasking Ridge, New Jersey, 07920, United States
-
MSK Bergen
RECRUITINGMontvale, New Jersey, 07645, United States
-
MSK Commack
RECRUITINGCommack, New York, 11725, United States
-
MSK Monmouth
RECRUITINGMiddletown, New Jersey, 07748, United States
-
MSK Nassau
RECRUITINGUniondale, New York, 11553, United States
-
MSK Westchester
RECRUITINGHarrison, New York, 10604, United States
-
Medizinische Universität Graz
RECRUITINGGraz, Styria, 8036, Austria
-
Medizinische Universität Wien
RECRUITINGVienna, 1090, Austria
-
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).
RECRUITINGNew York, New York, 10021, United States
-
Memorial Sloan Kettering Cancer Center-Main Campus
RECRUITINGNew York, New York, 10065, United States
-
Nanjing Drum Tower Hospital
RECRUITINGNanjing, Jiangsu, 210008, China
-
National Hospital Organization Okayama Medical Center
RECRUITINGOkayama, 701-1192, Japan
-
National Taiwan University Hospital
ACTIVE_NOT_RECRUITINGTaipei, 10002, Taiwan
-
North Shore Hospital
RECRUITINGAuckland, 0622, New Zealand
-
Nova Scotia Health Authority
RECRUITINGHalifax, Nova Scotia, B3S 0H6, Canada
-
Osaka Metropolitan University Hospital
RECRUITINGOsaka, 545-0051, Japan
-
Ospedale Santa Maria delle Croci
RECRUITINGRavenna, Emilia-Romagna, 48121, Italy
-
Oulu University Hospital
RECRUITINGOulu, 90220, Finland
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100091, China
-
Pindara Private Hospital
RECRUITINGBenowa, Queensland, 4217, Australia
-
Pratia Onkologia Katowice
ACTIVE_NOT_RECRUITINGKatowice, Silesian Voivodeship, 40-519, Poland
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
QEII Health Sciences Centre
RECRUITINGHalifax, Nova Scotia, B3H 2Y9, Canada
-
Rabin Medical Center
RECRUITINGPetah Tikva, Central District, 4910021, Israel
-
Royal Stoke University Hospital
RECRUITINGStoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom
-
Samsung Medical Center
RECRUITINGSeoul, Seoul-teukbyeolsi [seoul], 06351, South Korea
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam, Kyǒnggi-do, 13620, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, Seoul-teukbyeolsi [seoul], 03080, South Korea
-
Shizuoka Cancer Center
RECRUITINGNagaizumi-cho, Shizuoka, 411-8777, Japan
-
Soroka Medical Center
RECRUITINGBeersheba, Southern District, 8410101, Israel
-
Sourasky Medical Center
RECRUITINGTel Aviv, TELL ABĪB, 6423906, Israel
-
Southern Medical University Nanfang Hospital
RECRUITINGGuangzhou, Guangdong, 510515, China
-
St Vincent's Hospital Melbourne
RECRUITINGFitzroy, Victoria, 3065, Australia
-
Städtisches Klinikum Braunschweig
RECRUITINGBraunschweig, 38114, Germany
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510555, China
-
Taichung Veterans General Hospital
RECRUITINGTaichung, 407, Taiwan
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, 3004, Australia
-
The Beatson West of Scotland Cancer Centre
NOT_YET_RECRUITINGGlasgow, G12 0YN, United Kingdom
-
The Catholic Univ. of Korea Seoul St. Mary's Hospital
RECRUITINGSeoul, Seoul-teukbyeolsi [seoul], 06591, South Korea
-
The Catholic Univ. of Korea Seoul St. Mary's Hospital(Seoul St. Mary's Hospital)
RECRUITINGSeoul, Seoul-teukbyeolsi [seoul], 06591, South Korea
-
The Edmond and Lily Safra Children's Hospital; The Chaim Sheba Medical Center
RECRUITINGRamat Gan, Central District, 5265601, Israel
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, 215006, China
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
The first Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310003, China
-
The first Affiliated hospital of Wenzhou medical University
RECRUITINGWenzhou, Zhejiang, 325000, China
-
The first hospital of jilin university
RECRUITINGChangchun, Jilin, 130021, China
-
Tohoku University Hospital
RECRUITINGSendai, Miyagi, 980-8574, Japan
-
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430030, China
-
Tongji University - Shanghai Fourth People's Hospital
RECRUITINGShanghai, Shanghai Municipality, 200434, China
-
Turku University Hospital
RECRUITINGTurku, Southwest Finland, 20520, Finland
-
Uniklinikum Salzburg
RECRUITINGSalzburg, 5020, Austria
-
Universitaetsklinikum Tuebingen
RECRUITINGTübingen, Baden-Wurttemberg, 72076, Germany
-
Universitaetsklinikum Ulm
RECRUITINGUlm, Baden-Wurttemberg, 89081, Germany
-
University Hospital of Ioannina
RECRUITINGIoannina, Ípeiros, 455 00, Greece
-
University Hospital of Wales
RECRUITINGCardiff, CF14 4XW, United Kingdom
-
University of Fukui Hospital
RECRUITINGYoshida-gun, Fukui, 910-1193, Japan
-
Universitätsklinikum Aachen
NOT_YET_RECRUITINGAachen, 52074, Germany
-
Universitätsklinikum St. Pölten
RECRUITINGSankt Pölten, Lower Austria, 3100, Austria
-
Universitätsmedizin Johannes Gutenberg Universität Mainz
RECRUITINGMainz, Rhineland-Palatinate, 55131, Germany
-
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi
RECRUITINGYvoir, Namur, 5530, Belgium
-
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu
ACTIVE_NOT_RECRUITINGWroclaw, Lower Silesian Voivodeship, 50-367, Poland
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGdansk, Pomeranian Voivodeship, 80-214, Poland
-
Vseobecna fakultni nemocnice v Praze
RECRUITINGPrague, 12808, Czechia
-
Waikato Hospital
RECRUITINGHamilton, Waikato Region, 3204, New Zealand
-
Western General Hospital
NOT_YET_RECRUITINGEdinburgh, Midlothian, EH4 2XU, United Kingdom
-
Yamagata University Hospital
RECRUITINGYamagata, 990-9585, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cheap blood count ratios eyed as window into Myeloma's inflammatory grip
- Can a t-cell engager rescue myeloma that outsmarted CAR-T?
- Can myeloma treatment work without steroids?
- Double-Drug attack on Hard-to-Treat lymphomas
- Banking blood and bone marrow to decode plasma cell disorders
- Which scan sees hidden myeloma better: PET or MRI?